Literature DB >> 8082227

Time-dependent changes in body temperature rhythm induced in rats by brewer's yeast injection.

B Bruguerolle1, X Roucoules.   

Abstract

The aim of the present work was to document the possible influence of the time of administration of brewer's yeast on a model of fever previously reported. Forty male Wistar AF IOPS rats were recorded every hour for 24 h; 2 days later, five groups (four animals each) were injected subcutaneously (neck) at 09:00 or 20:00 h with four different doses of brewer's yeast (group A, 2.5 g/kg; group B, 2 g/kg; group C, 1.5 g/kg; group D, 1 g/kg) or with the equivalent volume of saline (group E, controls). Rectal temperature was recorded every hour for 24 h with an electronic thermometer with a thermistor probe inserted rectally. All data were quantified (means +/- SEM) and compared by analysis of variance (two ways). The circadian variations of temperature were assessed by cosinor analysis. Brewer's yeast-induced fever was statistically significant since increases of 01.04 to 0.77 degrees C and of 0.47 to 0.73 degrees C were observed compared with matched controls after the morning and the evening administration, respectively. A significant circadian rhythm of temperature was detected (p < 0.001) in controls before and during the experiments and in the differently treated groups. The effect of brewer's yeast was different according to the hour of its administration: after morning injection, the mesor of the circadian rhythm was significantly increased as compared with controls and the acrophase was significantly shifted in proportion to the dose. Concerning the evening dosing, the amplitude and the mesor of the circadian rhythm were increased and the acrophase was significantly shifted. During the 4 h following injection, brewer's yeast may induce hyper- or hypothermia.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8082227     DOI: 10.3109/07420529409057238

Source DB:  PubMed          Journal:  Chronobiol Int        ISSN: 0742-0528            Impact factor:   2.877


  8 in total

1.  A new cationic palladium(II) dithiocarbamate exhibits anti-inflammatory, analgesic, and antipyretic activities through inhibition of inflammatory mediators in in vivo models.

Authors:  Muhammad Naveed; Shahan Zeb Khan; Sara Zeeshan; Adnan Khan; Bushra Shal; Ayesha Atiq; Hussain Ali; Rahim Ullah; Salman Khan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-04-09       Impact factor: 3.000

Review 2.  Circadian rhythmicity of body temperature and metabolism.

Authors:  Roberto Refinetti
Journal:  Temperature (Austin)       Date:  2020-04-17

3.  Pharmacokinetic-pharmacodynamic modeling of the inhibitory effects of naproxen on the time-courses of inflammatory pain, fever, and the ex vivo synthesis of TXB2 and PGE2 in rats.

Authors:  Elke H J Krekels; Marie Angesjö; Ingemo Sjögren; Kristina Angeby Möller; Odd-Geir Berge; Sandra A G Visser
Journal:  Pharm Res       Date:  2011-02-23       Impact factor: 4.200

4.  N-Acetylcysteine prevents baker's-yeast-induced inflammation and fever.

Authors:  Ana Paula Oliveira Ferreira; Juliana Saibt Martins Pasin; André Luis Lopes Saraiva; Viviane Ratzlaff; Mateus Fortes Rossato; Rosália Andrighetto; Maribel Antonello Rubin; Juliano Ferreira; Carlos Fernando Mello
Journal:  Inflamm Res       Date:  2011-11-08       Impact factor: 4.575

5.  Preliminary phytochemical analysis and in vivo evaluation of antipyretic effects of hydro-methanolic extract of Cleome scaposa leaves.

Authors:  Waheed Mumtaz Abbasi; Saeed Ahmad; Sajida Perveen; Tayyeba Rehman
Journal:  J Tradit Complement Med       Date:  2017-05-29

6.  In vivo evaluation of antipyretic effects of some homeopathic ultra-high dilutions on Baker's yeast-induced fever on Similia principle.

Authors:  Saeed Ahmad; Tayyeba Rehman; Waheed Mumtaz Abbasi
Journal:  J Ayurveda Integr Med       Date:  2017-12-06

7.  Pharmacological evaluation of the gabapentin salicylaldehyde derivative, gabapentsal, against tonic and phasic pain models, inflammation, and pyrexia.

Authors:  Nisar Ahmad; Fazal Subhan; Nazar Ul Islam; Muhammad Shahid; Naseem Ullah; Rahim Ullah; Muhammad Khurram; Muhammad Usman Amin; Shehla Akbar; Ihsan Ullah; Robert D E Sewell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-07-12       Impact factor: 3.000

8.  Pharmacological basis for the use of Hypericum oblongifolium as a medicinal plant in the management of pain, inflammation and pyrexia.

Authors:  Naila Raziq; Muhammad Saeed; Muhammad Shahid; Naveed Muhammad; Haroon Khan; Farah Gul
Journal:  BMC Complement Altern Med       Date:  2016-02-01       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.